Skip to main content
. 2022 Feb 23;14(5):1151. doi: 10.3390/cancers14051151

Table 5.

Distribution of surrogated molecular types in breast cancer with cutaneous metastasis in different series.

Authors n Luminal HER2−
n (%)
HER2+
n (%)
TN
n (%)
Unknown
n (%)
Yates y col. [39] 19 9 (47) 2 (10) 5 (26) 3 (16)
Kong y col. [15] 125 53 (42.4) 43 (34) 29 (23)
Luna y col. [38] 26 7 (27) 7 (27) 10 (39) 2 (7)
González-Martínez y col. [37] 58 29 (50) 8 (14) 15 (26) 6 (10)
Present series 33 16 (48.5) 5 (15.2) 12 (36.4)